Novel Compounds Targeting InhA for TB Therapy
Tuberculosis (TB) is described as lethal disease in the world. Resistant to TB drugs is the main reason to have unfavourable outcomes in the treatment of TB. Therefore, new agents to replace existing drugs are urgently needed. Previous reports suggested that InhA inhibitors, an enoyl-ACP-reductase,...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018
|
| Subjects: | |
| Online Access: | http://umpir.ump.edu.my/id/eprint/19673/ http://umpir.ump.edu.my/id/eprint/19673/ http://umpir.ump.edu.my/id/eprint/19673/ http://umpir.ump.edu.my/id/eprint/19673/1/Novel%20compounds%20targeting%20InhA%20for%20TB%20therapy-fist-2018.pdf |